Morphine and dipyrone co-administration delays tolerance development and potentiates antinociception

By Hernandez-Delgadillo G.P.   Lopez-Munoz F.J.   Salazar L.A.   Cruz S.L.  

European Journal of Pharmacology, Vol. 469, Iss. 1, 2003-05 ,pp. : 71-79

Elsevier

Access to resources Recommend Favorite

Pharmacokinetics of Rofecoxib: A Specific Cyclo-Oxygenase-2 Inhibitor

By Davies N.M.  

Clinical Pharmacokinetics, Vol. 42, Iss. 6, 2003-01 ,pp. : 545-556

Adis International

Access to resources Recommend Favorite

The cyclo-oxygenase-2 inhibitor, rofecoxib, attenuates mucosal damage due to colitis induced by trinitrobenzene sulphonic acid in rats

By Martin A.R.   Villegas I.   La Casa C.   Alarcon de la Lastra C.  

European Journal of Pharmacology, Vol. 481, Iss. 2, 2003-11 ,pp. : 281-291

Elsevier

Access to resources Recommend Favorite

-Opioid receptor agonist U50,488H modulates cocaine and morphine self-administration in drug-naive rats and mice

By Kuzmin A.V.   Semenova S.   Gerrits M.A.F.M.   Zvartau E.E.   Van Ree J.M.  

European Journal of Pharmacology, Vol. 321, Iss. 3, 1997-03 ,pp. : 265-271

Elsevier

Access to resources Recommend Favorite

In mononeuropathic rats, the enhancement of morphine antinociception by L-365,260, a selective CCK B receptor antagonist, depends on the dose of systemic morphine and stimulus characteristics

By Idanpaan-Heikkila J.J.   Perrot S.   Guilbaud G.   Kayser V.  

European Journal of Pharmacology, Vol. 325, Iss. 2, 1997-05 ,pp. : 155-164

Elsevier

Access to resources Recommend Favorite